This is not the most recent version of the article. View current version (11 JUL 2012)

Intervention Protocol

Alprazolam for depression

  1. Harm van Marwijk1,*,
  2. Arjan Bax2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 23 APR 2008

DOI: 10.1002/14651858.CD007139


How to Cite

van Marwijk H, Bax A. Alprazolam for depression (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007139. DOI: 10.1002/14651858.CD007139.

Author Information

  1. 1

    Institute for Extramural Medicine, Department of General Practice, Amsterdam, Netherlands

  2. 2

    VU University Medical Centre, Department of General Practice, Amsterdam, Netherlands

*Harm van Marwijk, Department of General Practice, Institute for Extramural Medicine, VU University Medical Centre, Van der Boechorststraat 7, Amsterdam, 2311 XH, Netherlands. hwj.vanmarwijk@vumc.nl. Harmvanmarwijk@hetnet.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH

This is not the most recent version of the article. View current version (11 JUL 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effectiveness, including tolerability and acceptibility, of alprazolam as monotherapy for major depression in comparison with placebo and conventional antidepressants antidepressant effect, in outpatients and patients in primary care.